Fundz

Allucent Appoints Hubert Bland as Chief Medical Officer and Norman Waters as Therapeutic Strategy Head

PRIVATENov 10, 2026
New to company · from GSK“Most recently, he served as vice president and UK country medical director at GSK”

Position

Chief Medical Officer

Company

Allucent

Hubert Bland
hubert.bland@allucent.com
CaryBiotechnology

Description

Allucent strengthens its expertise in drug development with the appointments of Hubert Bland as Chief Medical Officer and Norman Waters as Therapeutic Strategy Head for Infectious Disease. Both leaders bring extensive experience to support biopharma companies in navigating complex drug development processes.

Who to call at Allucent, and when

A new leader at Allucent brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Allucent raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Allucent, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Allucent. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Allucent

Location

Cary, North Carolina, United States

About

Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Allucent changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Patrick
Likely contact at this company
••••••••@••••••••

See Patrick's verified email →

Hubert
Likely contact at this company
••••••••@••••••••

See Hubert's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Allucent's next move

Learn about Strategic plan

Allucent changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.